Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1997 2
1998 1
1999 4
2000 2
2001 1
2002 1
2003 1
2004 2
2006 2
2007 9
2008 7
2009 5
2010 5
2011 18
2012 17
2013 13
2014 18
2015 16
2016 26
2017 19
2018 21
2019 17
2020 12
2021 10
2022 11
2023 8
2024 11
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

216 results

Results by year

Filters applied: . Clear all
Page 1
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, Palmer J, Weisdorf D, Treister NS, Cheng GS, Kerr H, Stratton P, Duarte RF, McDonald GB, Inamoto Y, Vigorito A, Arai S, Datiles MB, Jacobsohn D, Heller T, Kitko CL, Mitchell SA, Martin PJ, Shulman H, Wu RS, Cutler CS, Vogelsang GB, Lee SJ, Pavletic SZ, Flowers ME. Jagasia MH, et al. Among authors: cutler cs. Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1. doi: 10.1016/j.bbmt.2014.12.001. Epub 2014 Dec 18. Biol Blood Marrow Transplant. 2015. PMID: 25529383 Free PMC article.
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S. Miklos D, et al. Among authors: cutler cs. Blood. 2017 Nov 23;130(21):2243-2250. doi: 10.1182/blood-2017-07-793786. Epub 2017 Sep 18. Blood. 2017. PMID: 28924018 Free PMC article. Clinical Trial.
Production and regulatory issues for theranostics.
Giammarile F, Paez D, Zimmermann R, Cutler CS, Jalilian A, Korde A, Knoll P, Ayati N, Lewis JS, Lapi SE, Delgado Bolton RC, Kunikowska J, Estrada Lobato E, Urbain JL, Holmberg O, Abdel-Wahab M, Scott AM. Giammarile F, et al. Among authors: cutler cs. Lancet Oncol. 2024 Jun;25(6):e260-e269. doi: 10.1016/S1470-2045(24)00041-X. Lancet Oncol. 2024. PMID: 38821100 Review.
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML.
Garcia JS, Kim HT, Murdock HM, Ansuinelli M, Brock J, Cutler CS, Gooptu M, Ho VT, Koreth J, Nikiforow S, Romee R, Shapiro R, DeAngelo DJ, Stone RM, Bat-Erdene D, Ryan J, Contreras ME, Fell G, Letai A, Ritz J, Lindsley RC, Soiffer RJ, Antin JH. Garcia JS, et al. Among authors: cutler cs. Blood Adv. 2024 Feb 27;8(4):978-990. doi: 10.1182/bloodadvances.2023012120. Blood Adv. 2024. PMID: 38197938 Free PMC article.
Artificial intelligence in immunotherapy PET/SPECT imaging.
McGale JP, Chen DL, Trebeschi S, Farwell MD, Wu AM, Cutler CS, Schwartz LH, Dercle L. McGale JP, et al. Among authors: cutler cs. Eur Radiol. 2024 Sep;34(9):5829-5841. doi: 10.1007/s00330-024-10637-3. Epub 2024 Feb 15. Eur Radiol. 2024. PMID: 38355986 Review.
Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse.
Shapiro RM, Birch GC, Hu G, Vergara Cadavid J, Nikiforow S, Baginska J, Ali AK, Tarannum M, Sheffer M, Abdulhamid YZ, Rambaldi B, Arihara Y, Reynolds C, Halpern MS, Rodig SJ, Cullen N, Wolff JO, Pfaff KL, Lane AA, Lindsley RC, Cutler CS, Antin JH, Ho VT, Koreth J, Gooptu M, Kim HT, Malmberg KJ, Wu CJ, Chen J, Soiffer RJ, Ritz J, Romee R. Shapiro RM, et al. Among authors: cutler cs. J Clin Invest. 2022 Jun 1;132(11):e154334. doi: 10.1172/JCI154334. J Clin Invest. 2022. PMID: 35349491 Free PMC article.
Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism.
Flynn R, Paz K, Du J, Reichenbach DK, Taylor PA, Panoskaltsis-Mortari A, Vulic A, Luznik L, MacDonald KK, Hill GR, Nyuydzefe MS, Weiss JM, Chen W, Trzeciak A, Serody JS, Aguilar EG, Murphy WJ, Maillard I, Munn D, Koreth J, Cutler CS, Antin JH, Ritz J, Waksal SD, Zanin-Zhorov A, Blazar BR. Flynn R, et al. Among authors: cutler cs. Blood. 2016 Apr 28;127(17):2144-54. doi: 10.1182/blood-2015-10-678706. Epub 2016 Mar 16. Blood. 2016. PMID: 26983850 Free PMC article.
Alpha emitting nuclides for targeted therapy.
Hatcher-Lamarre JL, Sanders VA, Rahman M, Cutler CS, Francesconi LC. Hatcher-Lamarre JL, et al. Among authors: cutler cs. Nucl Med Biol. 2021 Jan;92:228-240. doi: 10.1016/j.nucmedbio.2020.08.004. Epub 2020 Sep 1. Nucl Med Biol. 2021. PMID: 33558017 Free PMC article. Review.
67Cu Production Capabilities: A Mini Review.
Mou L, Martini P, Pupillo G, Cieszykowska I, Cutler CS, Mikołajczak R. Mou L, et al. Among authors: cutler cs. Molecules. 2022 Feb 23;27(5):1501. doi: 10.3390/molecules27051501. Molecules. 2022. PMID: 35268600 Free PMC article. Review.
216 results